Evidence map›Paper›PMID 38438524›Full record

ArticleMolecular psychiatry2024

The complex etiology of autism spectrum disorder due to missense mutations of CHD8.

Taichi Shiraishi, Yuta Katayama, Masaaki Nishiyama, Hirotaka Shoji, Tsuyoshi Miyakawa, Taisuke Mizoo, Akinobu Matsumoto, Atsushi Hijikata, Tsuyoshi Shirai, Kouta Mayanagi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Male-Biased Social Deficits in Chd8Neuroscience bulletin · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. An entropic explanation of insistence on sameness in autism.Frontiers in computational neuroscience · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Taichi ShiraishiDivision of Cell Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Fukuoka, Fukuoka, 812-8582, Japan.ORCID 0009-0003-4422-1374
Yuta KatayamaDivision of Cell Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Fukuoka, Fukuoka, 812-8582, Japan.
Masaaki NishiyamaDepartment of Histology and Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, 920-8640, Japan.ORCID 0009-0002-6868-1749
Hirotaka ShojiDivision of Systems Medical Science, Center for Medical Science, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Tsuyoshi MiyakawaDivision of Systems Medical Science, Center for Medical Science, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.ORCID 0000-0003-0137-8200
Taisuke MizooDivision of Cell Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Fukuoka, Fukuoka, 812-8582, Japan.
Akinobu MatsumotoDivision of Biological Science, Graduate School of Science, Nagoya University, Nagoya, 464-8602, Japan.
Atsushi HijikataSchool of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.ORCID 0000-0003-4297-8368
Tsuyoshi ShiraiDepartment of Computer Bioscience, Nagahama Institute of Bio-Science and Technology, 1266 Tamura-Cho, Nagahama, Shiga, 526-0829, Japan.ORCID 0000-0002-2506-5738
Kouta MayanagiDepartment of Drug Discovery Structural Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Fukuoka, 812-8582, Japan.
Keiichi I NakayamaDivision of Cell Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Fukuoka, Fukuoka, 812-8582, Japan. nakayama.keiichi@tmd.ac.jp.
Kyushu University · JPFujita Health University · JPKanazawa University · JPNagahama Institute of Bio-Science and Technology · JPNagoya University · JPTokyo Medical and Dental University · JPTokyo University of Pharmacy and Life Sciences · JP

Funding

Japan Agency for Medical Research and Development (AMED) 23wm0425002MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06276MEXT | Japan Society for the Promotion of Science (JSPS) JP22H04922MEXT | Japan Society for the Promotion of Science (JSPS) JP23H00378Ministry of Education, Culture, Sports, Science and Technology (MEXT) JPMXP0621467949
6 · The paper itself

Abstract

CHD8 is an ATP-dependent chromatin-remodeling factor encoded by the most frequently mutated gene in individuals with autism spectrum disorder (ASD). Although many studies have examined the consequences of CHD8 haploinsufficiency in cells and mice, few have focused on missense mutations, the most common type of CHD8 alteration in ASD patients. We here characterized CHD8 missense mutations in ASD patients according to six prediction scores and experimentally examined the effects of such mutations on the biochemical activities of CHD8, neural differentiation of embryonic stem cells, and mouse behavior. Only mutations with high prediction scores gave rise to ASD-like phenotypes in mice, suggesting that not all CHD8 missense mutations detected in ASD patients are directly responsible for the development of ASD. Furthermore, we found that mutations with high scores cause ASD by mechanisms either dependent on or independent of loss of chromatin-remodeling function. Our results thus provide insight into the molecular underpinnings of ASD pathogenesis caused by missense mutations of CHD8.

Indexed as

Autism Spectrum DisorderDNA-Binding ProteinsMutation, MissenseTranscription FactorsAnimalsCell DifferentiationChromatin Assembly and DisassemblyEmbryonic Stem CellsFemaleHaploinsufficiencyHumansMaleMicePhenotypeCHD8 protein, humanDNA-Binding ProteinsTranscription Factors

Identifiers

PMID38438524
OpenAlexW4392757204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.